Cerdelga recommended for approval in type 1 Gaucher disease

View source ↗

Summary

The EMA recommends approval of Cerdelga for type 1 Gaucher disease, indicating regulatory consideration for this indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• Cerdelga (Eliglustat)